Julie Delyon

13PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Veterinary diagnosis and diagnosticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 10, 2023
TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro.

Julie Delyon, Anaïs Vallet, Mélanie Bernard-Cacciarella

|Feb 11, 2023
Endemic Kaposi's Sarcoma.

Perla El Zeinaty, Céleste Lebbé, Julie Delyon

|Jul 09, 2022
18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors.

Alexia Rivas, Julie Delyon, Antoine Martineau

|May 14, 2022
Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma.

Louise Pesqué, Julie Delyon, Coralie Lheure

|Jun 02, 2021
Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans.

Jessica Beaziz, Maxime Battistella, Julie Delyon

|Jun 02, 2021
Systemic Treatment Initiation in Classical and Endemic Kaposi's Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study.

Lina Benajiba, Jérôme Lambert, Roberta La Selva

Pageof 3

Frequent Collaborators

3 joint publications

Maxime Battistella

2 joint publications

Nicolas Dumaz

2 joint publications

Samia Mourah

2 joint publications

Baptiste Louveau